Considers the implications of privatizing the Food and Drug Administration's (FDA) review of the safety and efficacy of medical devices and drugs. Concludes that the FDA's flaws - namely, a risk avoidance culture and autocratic style of regulation - can only be accomplished by breaking the agency's monopolization of this review function.
Elizabeth Price Foley and Elizabeth C. Price,
Teaching the Elephant to Dance: Privatizing the FDA Review Process
, 51 Food & Drug L.J. 651
Available at: https://ecollections.law.fiu.edu/faculty_publications/419